Therapeuticsmd Stock Today
| TXMD Stock | USD 1.08 0.01 0.92% |
Performance0 of 100
| Odds Of DistressOver 83
|
TherapeuticsMD is trading at 1.08 as of the 1st of February 2025, a 0.92 percent decrease since the beginning of the trading day. The stock's lowest day price was 1.06. TherapeuticsMD has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 2nd of January 2025 and ending today, the 1st of February 2025. Click here to learn more.
TherapeuticsMD, Inc. operates as a womens healthcare company in the United States. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida. Therapeuticsmd operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. The company has 11.53 M outstanding shares of which 240.2 K shares are at this time shorted by private and institutional investors with about 0.28 trading days to cover. More on TherapeuticsMD
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
TherapeuticsMD Stock Highlights
| Co-Founder, CEO and Director | Robert Finizio |
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
TherapeuticsMD (TXMD) is traded on NASDAQ Exchange in USA. It is located in 951 Yamato Road, Boca Raton, FL, United States, 33431 and employs 1 people. TherapeuticsMD is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 12.45 M. TherapeuticsMD conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 11.53 M outstanding shares of which 240.2 K shares are at this time shorted by private and institutional investors with about 0.28 trading days to cover.
TherapeuticsMD currently holds about 27.08 M in cash with (48.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.86, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check TherapeuticsMD Probability Of Bankruptcy
Ownership AllocationThe market capitalization of TherapeuticsMD is $12.45 Million. 30% of TherapeuticsMD outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check TherapeuticsMD Ownership Details
TherapeuticsMD Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. TherapeuticsMD market risk premium is the additional return an investor will receive from holding TherapeuticsMD long position in a well-diversified portfolio.
| Risk Adjusted Performance | 4.0E-4 | |||
| Jensen Alpha | (0.15) | |||
| Total Risk Alpha | (1.09) | |||
| Treynor Ratio | (0.50) |
TherapeuticsMD Stock Against Markets
TherapeuticsMD Corporate Management
| Hugh MBA | Pres Director | Profile | |
| MD FACOG | CoFounder,CoCEO Officer | Profile | |
| Douglas Steelman | Vice Access | Profile | |
| Benjamin Foulk | Vice Resources | Profile | |
| Dedra Lyden | Vice Initiatives | Profile | |
| Joseph Ziegler | Principal Officer | Profile | |
| Daniella Silva | Chief Officer | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TherapeuticsMD. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade TherapeuticsMD Stock refer to our How to Trade TherapeuticsMD Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TherapeuticsMD. If investors know TherapeuticsMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TherapeuticsMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of TherapeuticsMD is measured differently than its book value, which is the value of TherapeuticsMD that is recorded on the company's balance sheet. Investors also form their own opinion of TherapeuticsMD's value that differs from its market value or its book value, called intrinsic value, which is TherapeuticsMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TherapeuticsMD's market value can be influenced by many factors that don't directly affect TherapeuticsMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TherapeuticsMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if TherapeuticsMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TherapeuticsMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.